Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs
Summary of the Progress and Challenges in the Repurposing Kinase Inhibitors as Broad-Spectrum Antiviral Therapies
Flip the DNA Nanoswitch, Power the Clinical App
A Molecular Interaction Detection Platform Uses a Gel-based Readout
Applications of CRISPR/Cas9 Technology in Translational Research on Solid-Tumor Cancers
Efforts Are Underway to Move CRISPR/Cas9 from Bench to Bedside
Crowdfunding for Science: Models of Best Practice
It’s Not Just the Science That Has to Be Memorable
For full access to this article login to GEN Select now.
Central Eastern Europe Targets Biotech
Questions Remain on Whether Fledgling Industry Will Find Enough Support to Thrive
- This year’s “BioForum 2011” conference in Lodz, Poland, exposed the good and the bad about Central Eastern Europe’s (CEE) biotech industry. The good news is that CEE is beginning to establish a biotech presence: there are over 200 companies (many of which are small start-ups) in the 10 countries ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.